Polychlorinated biphenyls (PCBs), and in particular non-dioxin-like (NDL) congeners, continue to pose a significant risk to the developing nervous system. PCB 95, a prevalent NDL congener in the human chemosphere, promotes dendritic growth in rodent primary neurons by activating calcium-dependent transcriptional mechanisms that normally function to link activity to dendritic growth. Activity-dependent dendritic growth is also mediated by calcium-dependent translational mechanisms involving mechanistic target of rapamycin (mTOR), suggesting that the dendrite-promoting activity of PCB 95 may also involve mTOR signaling. Here, we test this hypothesis using primary neuron-glia co-cultures derived from the hippocampi of postnatal day 0 Sprague Dawley rats. PCB 95 (1 nM) activated mTOR in hippocampal cultures as evidenced by increased phosphorylation of mTOR at ser2448. Pharmacologic inhibition of mTOR signaling using rapamycin (20 nM), FK506 (5 nM), or 4EGI-1 (1 µM), and siRNA knockdown of mTOR, or the mTOR complex binding proteins, raptor or rictor, blocked PCB 95-induced dendritic growth. These data identify mTOR activation as a novel molecular mechanism contributing to the effects of PCB 95 on dendritic arborization. In light of clinical data linking gain-of-function mutations in mTOR signaling to neurodevelopmental disorders, our findings suggest that mTOR signaling may represent a convergence point for gene by environment interactions that confer risk for adverse neurodevelopmental outcomes.
Introduction
There is credible evidence that environmental factors influence risk of neurodevelopmental disorders (NDDs), particularly in genetically susceptible individuals (Heyer and Meredith 2017; Lyall et al. 2017a) . However, the identification of environmental factors that influence NDD risk and the mechanisms by which they interact with genetic susceptibilities to influence NDD risk are largely unknown. Polychlorinated biphenyls (PCBs) have been implicated as NDD risk factors (Landrigan et al. 2012; Stamou et al. 2013) , and despite being banned from production since the late 1970s, PCBs remain persistent environmental toxicants with documented widespread exposure of pregnant women and young children (Herrick et al. 2007; Koh et al. 2016; Marek et al. 2017) . Perinatal exposure to PCBs is associated with neuropsychological deficits in children (Berghuis et al. 2015; Lyall et al. 2017b) , and confirmed in preclinical models (Sable and Schantz 2006; Ulbrich and Stahlmann 2004) .
Preclinical studies demonstrate that developmental exposures to Aroclor 1254 or to the NDL congener, PCB 95, enhance dendritic growth and alter dendritic plasticity in the developing brain coincident with deficits in spatial learning and memory (Wayman et al. 2012b; Yang et al. 2009 ). In primary hippocampal neurons, PCB 95 promotes dendritic growth via sensitization of ryanodine receptors (RyR) to release Ca 2+ from intracellular stores, which triggers Ca 2+ -dependent signaling pathways that activate transcriptional mechanisms of dendritic growth and spine formation (Lesiak et al. 2014; Wayman et al. 2012a ). These effects phenocopy NDDs, which are also associated with enhanced dendritic arborization (Copf 2016) and with mutations in genes that encode signaling molecules important in activity-dependent dendritic growth (Ebert and Greenberg 2013; Stamou et al. 2013) .
Activity-dependent dendritic growth is modulated not only by Ca 2+ -dependent transcriptional mechanisms (Pessah et al. 2010; Wayman et al. 2012a) , but also by Ca 2+ -dependent translational mechanisms mediated largely by mTOR signaling (Kindler and Kreienkamp 2012; Sosanya et al. 2015) . When activated, mTOR complex 1 (mTORC1), which includes mTOR, FK506-binding protein 12 (FKBP12), and the regulatory-associated protein of mTOR (raptor), phosphorylates 4EBP1/2, releasing eIF4E to bind eIF4GII, which initiates cap-dependent translation (Zhou and Huang 2010) . In contrast, mTOR complex 2 (mTORC2), which is comprised of mTOR and the rapamycin-insensitive companion of mTOR (rictor), phosphorylates Akt (protein kinase B), and is linked to cell autophagy and cytoskeleton regulation. mTOR activation increases dendritic outgrowth and synaptogenesis (Urbanska et al. 2012) , and mutations in both mTOR signaling pathways have been linked to increased risk for NDDs (Gipson and Johnston 2012; Switon et al. 2017; Troca-Marin et al. 2012; Wang and Doering 2013) . Collectively, these observations suggest that mTOR signaling may contribute to PCB 95-induced dendritic growth. Here, we test this hypothesis in primary rat hippocampal neurons. PCB 95 (2, 2′, 3, 5′, was purchased from AccuStandard, (Lot #010610KS, 99.7% pure, New Haven, CT). All PCB 95 stock solutions were made in dry sterile dimethylsulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO). Plasmids encoding microtubule-associated-protein-2B (MAP2B)-pCAG-fusion protein red (FusRed) or MAP2B fused to enhanced green fluorescent protein (MAP2B-pCAG-EGFP) were generously provided by Dr. Gary Wayman (University of Washington, Pullman, WA) and have been previously characterized (Wayman et al. 2006) . Predesigned Ambion Silencer Select siRNAs targeting mTOR (s132719), raptor (s143003), rictor (s160195), or scrambled siRNA (#4390844) were purchased from Thermo Fisher Scientific (Waltham, MA). FK506 was purchased from Cayman Chemical (Ann Arbor, MI); 4EGI-1, from Tocris (Minneapolis, MN); and rapamycin, from Selleckchem (Houston, TX).
Materials and methods

Materials
Animals
All procedures involving animals were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the University of California, Davis Institutional Animal Care and Use Committee. Timedpregnant Sprague Dawley rats were purchased from Charles River Laboratory (Hollister, CA). All animals were housed in clear plastic shoebox cages containing corn cob bedding under constant temperature (22 ± 2 °C) and a 12 h light-dark cycle. Food and water were provided ad libitum.
Cell culture
Primary hippocampal cell cultures were prepared from postnatal day (P) 0-P1 rat pups with hippocampi from both sexes pooled as described previously (Wayman et al. 2006) . Dissociated hippocampal cells were plated at a density of 83,000 cells/cm 2 on glass coverslips (Bellco Glass, Vineland, NJ) precoated with poly-L-lysine (0.5 mg/mL, SigmaAldrich) and maintained at 37 °C in NeuralQ Basal Medium supplemented with 2% GS21 (MTI-GlobalStem, Gaithersburg, MD) and 1% GlutaMAX (Thermo Fisher Scientific) under 5% CO 2 . On day in vitro (DIV) 4, cultures were treated with cytosine β-D-arabinofuranoside hydrochloride (2.5 µM, Sigma-Aldrich) to limit glia cell proliferation. On DIV 6, cells were transfected with either MAP2B-pCAG-FusRed or MAP2B-pCAG-EGFP plasmids using Lipofectamine-2000 (Invitrogen, Carlsbad, CA) per the manufacturer's instructions. A subset of cultures was co-transfected with 1 nM predesigned Ambion Silencer Select siRNAs. On DIV 7, cells were treated with one or more of the following: vehicle (DMSO; ≤ 0.2%), PCB 95 (1 nM), FK506 (5 nM), or 4EGI (1 µM) diluted from 1,000x stocks directly into culture medium. Rapamycin (20 nM) was added on DIV 6 to pretreat cultures for 24 h prior to addition of vehicle or PCB 95 on DIV 7.
Immunocytochemistry
Cultures were fixed on DIV 9 with 4% paraformaldehyde (PFA, Sigma-Aldrich) for 20 min, and then permeabilized and immunostained as previously described . Primary antibodies included rabbit anti-mTOR (1: 200, #2983, Cell Signaling, Danvers, MA), mouse anti-FKBP12 (1:100, sc-133067, Santa Cruz, Dallas, TX), and mouse anti RyR1/RyR2 (1:50, 34C, Developmental Studies Hybridoma Bank, Iowa City, IA). Secondary antibodies were purchased from Thermo Fisher Scientific and included goat anti-rabbit Alexa 568 IgG (1:500, A-11036), goat anti-rabbit Alexa 647 IgG H + L (1:500, A-21244), goat anti-mouse IgG2a Alexa 647 (1:500, A-21241), and goat anti-mouse IgG1 Alexa 568 (1:500, A-21124). Negative controls were reacted with secondary antibodies only. Images were acquired on a Nikon N-SIM using broad-band diffraction grating (405,488,561,640 nm) with a 100x NA 1.49 objective. Images were acquired in Nikon "3D-SIM" mode (three diffraction grating angles, five translations), which cuts ~ 350 nm optical section using interference patterns between − 1, + 1, and 0 order diffraction lines (Gustafsson et al. 2008 ). Images were processed using the Nikon Elements SIM software control module (reconstructed image pixel size = 0.032 µm). Image planes were further preprocessed in Fiji (Schindelin et al. 2012 ) utilizing the rolling ball method (radius10) prior to being imported into Imaris8.2 (Bitplane) (x, y = 0.0313 µm, z = 0.133 µm) to generate movies (see Supplementary material).
Phosphorylated mTOR ELISA
On DIV 7, cultures were exposed for 2 h to one or more of the following: vehicle (DMSO; ≤ 0.2%), PCB 95 (1 nM), and/or rapamycin (20 nM). Cultures were pretreated with rapamycin (20 nM) for 24 h prior to the addition of vehicle or PCB 95. A PathScan Phospho-mTOR (Ser2448) Sandwich ELISA Kit (#7976C, Cell Signaling Technology) was used per the manufacturer's instructions to detect phosphorylated mTOR in cell lysates. Protein concentration was determined using Pierce BCA Kit (Thermo Fisher Scientific). Absorbance was read at 450 nm using a Synergy H1 Reader (Biotek Instruments, Winooski, VT). Average absorbance values from two technical replicates were normalized to untreated control wells within a dissection. Results are reported as mean ± SEM fold change from untreated control from n = 4 independent dissections.
Morphometric analysis
On DIV 9, cells were fixed with 4% PFA and mounted to glass slides using ProLong Gold antifade reagent with DAPI (Thermo Fisher Scientific). Images of EGFP or FusRed positive neurons were captured using an ImageExpressXL highcontent imaging system (Molecular Devices, Sunnyvale, CA) with automated image acquisition software (Metaxpress Version 5.3.0.5, Molecular Devices). Neurons were chosen for morphological analyses using previously described criteria (Keil et al. 2017) . The dendritic morphology of individual neurons was quantified by an individual blinded to experimental conditions using ImageJ software (Schneider et al. 2012 ) with the Sholl analysis plug-in v3.4.2 (Ferreira et al. 2014) . Dendritic morphology was measured in neurons from three coverslips per group per dissection, using cultures prepared from at least three independent dissections. Data used to generate figures include neurons from at least 2-3 independent dissections.
Statistics
Data were tested for normality using Kolmogorov-Smirnov, D'Agostino and Pearson omnibus, and Shapiro-Wilk normality tests and Bartlett's test for equal variance using GraphPad Prism v 6.07 (San Diego, CA). Differences between two groups were assessed using Student's T test or Student's T Test with Welch's correction for parametric data and by the Mann-Whitney U test for nonparametric data. Differences between three or more groups were assessed using a one-way analysis of variance (ANOVA) with p set at 0.05 followed by Tukey's multiple comparison test for parametric data or Kruskal-Wallis test with Dunn's multiple comparison test for nonparametric data. Values for the area under the curve, distance from soma of peak intersection (peak X), and maximum dendritic intersections (peak Y) were calculated from Sholl profiles using the built in area under the curve analysis in GraphPad Prism Software. All results are reported as mean ± SEM.
Results
Primary hippocampal neuron-glia co-cultures express mTOR, FKBP12, and RyR1/2
The co-localization of mTOR, FKBP12, and RyR1/2 in primary hippocampal neurons was confirmed using structured illumination microscopy (SIM). Immunoreactivity for mTOR, RyR1/2 and FKBP12 was observed in close physical proximity in the soma and dendrites of DIV 9 hippocampal neurons ( Fig. 1 and Supplemental movies 1, 2). mTOR was primarily localized surrounding the nucleus, while FKBP12 was present in both the perinuclear space as well as the nucleus (Fig. 1a) . Both mTOR and FKBP12 were also present in distal dendrites (Fig. 1b) . RyR1/2 displayed distinct punctuate staining surrounding the nucleus and was present in distal dendrites (Fig. 1c, d ). RyR1/2 and mTOR immunoreactivity was present in MAP2B immunopositive processes (Fig. 1e, f) .
PCB 95 promotes dendritic growth via mTOR activation
To determine whether PCB 95 activates mTOR at a concentration (1 nM) that promotes dendritic growth (Wayman et al. 2012a ), we used a sandwich ELISA to quantify mTOR phosphorylated on Ser2448. Phosphorylated mTOR was significantly increased in DIV 7 hippocampal cultures exposed to PCB 95 (1 nM) for 2 h relative to vehicle control cultures (Fig. 2b) . PCB 95-induced phosphorylation of mTOR activation was blocked by the mTOR inhibitor, rapamycin (Fig. 2b) .
To determine whether mTOR activation is causally linked to PCB 95-induced dendritic growth, we quantified dendritic growth in PCB-exposed cultures treated with pharmacologic agents that block mTOR signaling by interfering with mTOR interactions with FKBP12 (Fig. 2a) . As determined by Sholl analysis, rapamycin blocked PCB 95-induced dendritic growth (Fig. 2c-f) . Notably, rapamycin did not alter dendritic growth in vehicle control cultures (Fig. 2) . To confirm the rapamycin observations, we used a different pharmacological inhibitor of the mTOR pathway, FK506, which acts to disrupt the interaction between FKBP12 and the mTOR complex (Schreiber et al. 2015) . While FK506 had no effect on dendritic growth in vehicle control cultures, it significantly inhibited PCB 95-induced dendritic growth (Fig. 3) .
To corroborate findings obtained using pharmacologic inhibition of mTOR signaling, we assessed the effects of (Fig. 4a, b) . In contrast, transfection with mTOR siRNA significantly inhibited PCB 95-induced dendritic growth (Fig. 4c, d ). In vehicle control cultures, transfection with mTOR siRNA did not alter dendritic growth compared to cultures transfected with control siRNA (Total AUC, control siRNA 2906 ± 171 vs. mTOR siRNA 3192 ± 120; p = 0.16).
Relative roles of mTORC1 vs. mTORC2 in PCB 95-induced dendritic growth
mTOR forms two distinct signaling complexes, mTORC1 and mTORC2, which are in part discriminated by unique partner proteins, raptor and rictor, respectively (Foster and Fingar 2010) and by their sensitivity to rapamycin. Our earlier observation that rapamycin and FK506 blocked PCB 95-induced dendritic growth strongly implicates mTORC1 in mediating PCB 95 effects on dendritic arborization. To confirm that mTOR-dependent translational mechanisms are recruited during PCB 95-induced dendritic growth, we used 4EGI-1, a pharmacologic agent that inhibits eIF4GII from complexing with eIF4E (Fig. 2a) , thereby blocking mTORC1-controlled cap-dependent translation without directly affecting the upstream mTOR complex (Huber et al. 2015; Zhou and Huang 2010) . Treatment with 4EGI-1 significantly inhibited PCB 95-induced dendritic growth but had no effect on dendritic arborization in vehicle control cultures (Fig. 5) .
To test the relative roles of mTORC1 and mTORC2 in PCB 95-induced dendritic arborization, cultures were transfected with siRNA specific for their defining binding partners, raptor and rictor. siRNA knockdown of either raptor or rictor significantly inhibited PCB 95-induced dendritic growth (Fig. 6) . Transfection with raptor siRNA also significantly decreased dendritic arborization in vehicle control cultures (Fig. 6) . In contrast, blocking mTORC2 by transfection with rictor siRNA caused no significant change in dendritic arborization in vehicle control cultures (Fig. 6 ).
Discussion
Our results identify a novel mechanism of PCB developmental neurotoxicity in which PCBs promote dendritic growth by activating mTOR signaling. The evidence supporting this model includes: (1) PCB 95 increases mTOR phosphorylation in primary hippocampal cell cultures, and this effect is blocked by rapamycin; and (2) PCB 95-induced dendritic arborization is significantly inhibited by pharmacologic blockade of mTOR or the downstream signaling molecule 4EGI-1, and by siRNA knockdown of mTOR or the mTOR complex proteins, raptor and rictor. These data extend previous reports of PCB effects on mTOR signaling in hepatic cell lines (Hardesty et al. 2017; Shi et al. 2016) , although in these studies Aroclor 1260 and a quinone metabolite of PCB 29 were observed to inhibit mTOR signaling. The reason(s) for the discrepant effects of PCBs on mTOR are not known but likely reflect differences with respect to the model systems (primary neurons vs. hepatic cell lines) and/or the PCB congeners investigated. However, our findings are consistent with recent observations that Atlantic killifish exposed to high PCB levels in the New Bedford Harbor express elevated levels of mTOR compared to Atlantic killifish from cleaner waters (Fritsch et al. 2015) .
A key question raised by these studies is how PCB 95 activates mTOR. Our immunocytochemical analyses of primary hippocampal neurons indicating that RyRs are in close physical proximity to mTOR and FKBP12, suggest a model in which PCB 95 sensitization of neuronal RyRs increases local concentrations of intracellular Ca 2+ ([Ca 2+ ] i ), which then activate mTOR (Fig. 2a) . In support of this model, PCB 95 has potent RyR activity (Holland et al. 2017) , directly binding to and stabilizing these Ca 2+ ion channels in their open configuration (Pessah et al. 2010) , and PCB 95-RyR interactions have been causally linked to increased [Ca 2+ ] i in primary hippocampal neurons (Wayman et al. 2012a) . In further support of this model, several lines of evidence demonstrate that mTOR is activated by increased [Ca 2+ ] i : (i) Ca 2+ is required for mTORC1 signaling (Gulati et al. 2008 ) and (ii) calmodulin binds mTORC1 to activate its kinase activity in a Ca 2+ -dependent manner (Li et al. 2016) . Collectively, these observations support a model in which PCB 95 activates mTORC1 via Ca 2+ -dependent mechanisms downstream of RyR sensitization.
Alternatively, PCB 95 may promote mTOR signaling via interactions with the immunophilin, FKBP12 (Fig. 2a) . FKBP12 is a functional component of mTORC1 ( Zhou   Fig. 4 mTOR siRNA blocks PCB 95-induced dendritic growth. a, c Representative images of DIV 9 neurons transfected with MAP2B-FusRed and either control (scrambled) siRNA or mTOR siRNA. b, d Dendritic complexity was assessed by quantifying total area under the Sholl curve. Data presented as mean ± SEM (n = 35-65 neurons per group from at least three independent dissections); differences between groups identified by the Mann Whitney U test. *p ≤ 0.05; ns not significant and Huang 2010), and FKBP12 is also required for PCB 95 sensitization of RyRs (Pessah et al. 2010) . Rapamycin and FK506 block mTOR signaling by binding to FKBP12 to alter its activity (Ballou and Lin 2008; Sarbassov et al. 2006 ), and we observed that these pharmacologic agents blocked PCB 95 effects on mTOR activation and dendritic arborization in hippocampal neurons. One interpretation of these data is that rapamycin and FK506 block RyR sensitization by PCB 95, thereby preventing Ca 2+ -dependent activation of mTOR; the alternative interpretation is that PCB 95 interacts directly with mTORC complexes via FKBP12. Distinguishing between these possibilities is the focus of future studies.
Results from our studies of the relative roles of mTORC1 and mTORC2 in dendritic growth were surprising. These mTORC complexes are differentiated by their sensitivity to rapamycin, with mTORC1 being sensitive, while mTORC2 is relatively insensitive (Sarbassov et al. 2006) , as well as their interaction with FKBP12, which is unique to mTORC1 (Marz et al. 2013) . Because both rapamycin and FK506 blocked PCB 95-induced dendritic growth, we anticipated that siRNA knockdown of raptor, but not rictor, would significantly inhibit the dendrite-promoting activity of PCB 95. However, we observed that siRNA knockdown of either raptor or rictor blocked PCB 95-induced dendritic growth. Two interpretations of these data are: (i) activity of both mTORC1 and mTORC2 are required for PCB effects on dendritic growth, perhaps with mTORC2 activating mTORC1 via AKT signaling (Switon et al. 2017) ; and/or (ii) rapamycin and FK506 effects on PCB 95-induced dendritic growth are mediated at the level of the RyR.
Another unexpected outcome was that inhibition of mTORC1 with raptor siRNA knockdown decreased dendritic complexity in vehicle control cultures, whereas inhibition of mTORC2 with rictor siRNA knockdown had no effect in the absence of PCB 95. This suggests that basal dendritic arborization may rely more on mTORC1 than mTORC2 signaling. In support of this, targeted deletion of raptor in the brain severely reduces neural cell number, size, and differentiation and results in early postnatal death , whereas targeted deletion of rictor in the brain causes non-lethal microcephaly (Angliker et al. 2015; Thomanetz et al. 2013) . Similarly, comparative studies of mice with targeted deletion of either raptor or rictor in Purkinje cells revealed more pronounced effects of mTORC1 on Purkinje cell soma size, electrophysiology, cell survival and behavior (Angliker 2015) . However, both genotypes increased dendritic arborization of Purkinje cells (Angliker et al. 2015) . Similarly, both mTORC1 and mTORC2 signaling promote dendritic growth in olfactory bulb neurons (Skalecka et al. 2016 ) and hippocampal neurons (Urbanska et al. 2012) . Consistent with these observations, inhibition of either mTORC1 or mTORC2 activity by siRNA knockdown of raptor or rictor, respectively, blocked the dendrite promoting activity of PCB 95.
Dendritic morphology is a major determinant of neuronal connectivity that is often perturbed in NDDs, and genes important for regulating dendritic shape and size during development have been identified as genetic risk factors in many NDDs (Copf 2016; Ebert and Greenberg 2013; Penzes et al. 2011; Stamou et al. 2013) . Because of its well-established role in regulating dendritic growth and synaptic density (Urbanska et al. 2012) , it is not surprising that mTOR signaling has been implicated in the pathogenesis of several NDDs (Gipson and Johnston 2012; Wang and Doering 2013) . Collectively, these published data, together with the findings of this study, identify mTOR signaling as a convergence point for gene by environment interactions that confer risk for adverse neurodevelopmental outcomes. In support of this, increasing experimental and epidemiological evidence link environmental PCBs to elevated risk for NDDs (Korrick and Sagiv 2008; Lyall et al. 2017b; Stamou et al. 2013) , and PCB 95 levels are higher in post-mortem brain tissue of children diagnosed with a syndromic form of autism relative to neurotypical controls (Mitchell et al. 2012) . This, together with the known role of PCB 95 in inducing dendritic growth in rodent models both in vivo and in vitro (Wayman et al. 2012a, b; Yang et al. 2009 ), suggest that PCB 95, and potentially other RyR-active environmental chemicals, interact with mutations in the mTOR signaling pathway to alter dendritic complexity and increase NDD risk. Fig. 6 PCB 95-induced dendritic growth requires both mTORC1 and mTORC2. a Representative images of DIV 9 neurons transfected with MAP2B-EGFP and either control (scrambled) siRNA, raptor siRNA (mTORC1), or rictor siRNA (mTORC2) following 48 h exposure to vehicle (Veh) or PCB 95 (1 nM). b Dendritic complexity was assessed by quantifying total area under the Sholl curve. Data presented as mean ± SEM (n = 43-97 neurons per group from at least two independent dissections). Differences between groups identified by one-way ANOVA with post hoc Newman-Keuls multiple comparison test. *p ≤ 0.05 Human Development (F32 HD088016); GWM, by a postdoctoral fellowship from the National Institute of Environmental Health Sciences (F32 ES024070); and SS and HC by predoctoral fellowships from the National Institute of Environmental Health Sciences (T32 ES007059). This research used the Biological Analysis Core of the UC Davis MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125). We also acknowledge support provided by Michael Paddy, Director of the Molecular and Cell Biology Light Microscope Imaging Facility (UC Davis CRCF Core Facility) for use of the Nikon SIM (acquired via NIH Grant 1 S10 RR029304-0). The funding agencies were not involved in experimental design, data analysis or decision to publish, and the content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Furthermore, the funding agencies do not endorse the purchase of any commercial products or services mentioned in the publication.
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